{
    "id": "5c6583117c78d69471000002",
    "question": "Can midostaurin inhibit angiogenesis?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To determine whether midostaurin inhibits angiogenesis, we need to understand what midostaurin is and its mechanism of action. Midostaurin is a small molecule kinase inhibitor that targets the fibroblast growth factor receptor (FGFR) family, particularly FGFR1, FGFR2, and FGFR3. It is primarily used in the treatment of acute myeloid leukemia (AML). Angiogenesis is the process by which new blood vessels form from pre-existing vessels, and it is a critical component of tumor growth and metastasis. Given that midostaurin inhibits FGFRs, which are involved in signaling pathways that promote angiogenesis, it is reasonable to infer that midostaurin may inhibit angiogenesis. Additionally, midostaurin has been shown to have anti-angiogenic effects in preclinical studies by inhibiting the phosphorylation and activation of downstream signaling molecules involved in angiogenesis. Therefore, based on its mechanism of action and preclinical data, it is likely that midostaurin inhibits angiogenesis.\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 6.371147155761719
}